Éric Grignano

1.2k total citations
23 papers, 452 citations indexed

About

Éric Grignano is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Éric Grignano has authored 23 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Hematology and 7 papers in Oncology. Recurrent topics in Éric Grignano's work include Chronic Lymphocytic Leukemia Research (5 papers), Acute Myeloid Leukemia Research (4 papers) and Ferroptosis and cancer prognosis (4 papers). Éric Grignano is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Acute Myeloid Leukemia Research (4 papers) and Ferroptosis and cancer prognosis (4 papers). Éric Grignano collaborates with scholars based in France, United States and Canada. Éric Grignano's co-authors include Didier Bouscary, Nicolas Chapuis, Rudy Birsen, Michaëla Fontenay, Olivier Kosmider, A. Mékinian, O. Fain, Pierre Fenaux, Patrick Mayeux and Jérôme Tamburini and has published in prestigious journals such as Blood, Journal of Antimicrobial Chemotherapy and Medicine.

In The Last Decade

Éric Grignano

19 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Éric Grignano France 9 191 152 146 101 98 23 452
Gevorg Tamamyan Armenia 7 200 1.0× 85 0.6× 93 0.6× 111 1.1× 86 0.9× 49 402
Lola Luo United States 8 128 0.7× 69 0.5× 164 1.1× 62 0.6× 113 1.2× 8 403
Wilhelm Wößmann Germany 11 276 1.4× 119 0.8× 127 0.9× 67 0.7× 101 1.0× 23 544
Samah Nassereddine United States 9 118 0.6× 44 0.3× 199 1.4× 49 0.5× 78 0.8× 20 375
José A. López United States 10 161 0.8× 73 0.5× 237 1.6× 41 0.4× 63 0.6× 19 500
Joseph Catlett United States 11 151 0.8× 129 0.8× 84 0.6× 25 0.2× 170 1.7× 15 501
Francesco Mendicino Italy 12 152 0.8× 46 0.3× 224 1.5× 19 0.2× 106 1.1× 52 433
Laurie Gashin United States 6 148 0.8× 36 0.2× 121 0.8× 33 0.3× 209 2.1× 9 527
Chang Ki Min South Korea 11 125 0.7× 60 0.4× 177 1.2× 17 0.2× 163 1.7× 38 416
Rika Kasajima Japan 10 129 0.7× 90 0.6× 71 0.5× 126 1.2× 133 1.4× 37 350

Countries citing papers authored by Éric Grignano

Since Specialization
Citations

This map shows the geographic impact of Éric Grignano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Grignano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Grignano more than expected).

Fields of papers citing papers by Éric Grignano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Grignano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Grignano. The network helps show where Éric Grignano may publish in the future.

Co-authorship network of co-authors of Éric Grignano

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Grignano. A scholar is included among the top collaborators of Éric Grignano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Grignano. Éric Grignano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cathelin, Séverine, David Dai, Éric Grignano, et al.. (2025). Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitors. PubMed. 3(1). 100182–100182.
2.
Cathelin, Séverine, David Dai, Éric Grignano, et al.. (2024). Single-Cell Proteogenomic Analysis of Clonal Evolution in Patient-Derived Xenograft Models of AML Treated with IDH Inhibitors. Blood. 144(Supplement 1). 4995–4995.
3.
Beuvon, Frédéric, Lise Willems, Éric Grignano, et al.. (2023). Management of Gastro-Intestinal Toxicity of the Pi3 Kinase Inhibitor: Optimizing Future Dosing Strategies. Cancers. 15(8). 2279–2279. 1 indexed citations
4.
Grignano, Éric, Jérémie Zerbit, Justine Decroocq, et al.. (2023). Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein. Cell Death Discovery. 9(1). 97–97. 38 indexed citations
5.
Contejean, Adrien, Salam Abbara, Sophie Alviset, et al.. (2022). Antimicrobial stewardship in high-risk febrile neutropenia patients. Antimicrobial Resistance and Infection Control. 11(1). 52–52. 23 indexed citations
6.
Zerbit, Jérémie, Marie Kroemer, Justine Decroocq, et al.. (2022). Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis. European Journal of Cancer Care. 31(6). e13753–e13753. 6 indexed citations
7.
Birsen, Rudy, Éric Grignano, Nicolas Chapuis, & Didier Bouscary. (2021). Ferroptose et cancer. médecine/sciences. 37(8-9). 726–734.
8.
Birsen, Rudy, Clément Larrue, Justine Decroocq, et al.. (2021). APR-246 induces early cell death by ferroptosis in acute myeloid leukemia. Haematologica. 107(2). 403–416. 131 indexed citations
9.
Grignano, Éric, Rudy Birsen, Nicolas Chapuis, & Didier Bouscary. (2020). From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells. Frontiers in Oncology. 10. 586530–586530. 40 indexed citations
10.
Contejean, Adrien, Sihem Benaboud, Jean‐Marc Tréluyer, et al.. (2020). A meropenem pharmacokinetics model in patients with haematological malignancies. Journal of Antimicrobial Chemotherapy. 75(10). 2960–2968. 7 indexed citations
11.
Boilève, Alice, Éric Grignano, Nathalie Franck, et al.. (2020). Acute and fatal cephalosporin‐induced autoimmune haemolytic anaemia. British Journal of Clinical Pharmacology. 87(4). 2152–2156. 1 indexed citations
12.
Boilève, Alice, Adrien Contejean, Élise Sourdeau, et al.. (2019). Mastocytosis onset in a patient with treated hairy cell leukemia: Just a coincidence?. Blood Cells Molecules and Diseases. 81. 102392–102392.
13.
Boilève, Alice, Adrien Contejean, Éric Grignano, et al.. (2019). Partial response in hairy cell leukemia with vemurafenib despite early discontinuation due to agranulocytosis. Anti-Cancer Drugs. 31(2). 196–198. 1 indexed citations
14.
Grignano, Éric, Bénédicte Deau, Gokoulakrichenane Loganadane, et al.. (2018). Radiotherapy of relapse-refractory follicular lymphoma. Cancer/Radiothérapie. 22(2). 126–130. 5 indexed citations
15.
Grignano, Éric, Vincent Jachiet, Pierre Fenaux, et al.. (2018). Autoimmune manifestations associated with myelodysplastic syndromes. Annals of Hematology. 97(11). 2015–2023. 46 indexed citations
16.
Jachiet, Vincent, A. Mékinian, Fabrice Carrat, et al.. (2017). Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study. Leukemia & lymphoma. 59(6). 1399–1405. 16 indexed citations
17.
Grignano, Éric, A. Mékinian, Thorsten Braun, et al.. (2016). Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review. Leukemia Research. 47. 136–141. 36 indexed citations
18.
Grignano, Éric, et al.. (2016). Manifestations auto-immunes et inflammatoires des hémopathies lymphoïdes. La Revue de Médecine Interne. 38(6). 374–382. 5 indexed citations
19.
Mékinian, A., Thorsten Braun, Éric Grignano, et al.. (2015). Hypervitaminémie B12 dans les syndromes myélodysplasiques : facteur de mauvais pronostic ?. La Revue de Médecine Interne. 36. A73–A74. 1 indexed citations
20.
Mékinian, A., Thorsten Braun, Olivier Decaux, et al.. (2013). Inflammatory Arthritis in Patients With Myelodysplastic Syndromes. Medicine. 93(1). 1–10. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gevorg Tamamyan Breakdown of academic impact, for papers by Lola Luo Breakdown of academic impact, for papers by Wilhelm Wößmann Breakdown of academic impact, for papers by Samah Nassereddine Breakdown of academic impact, for papers by José A. López Breakdown of academic impact, for papers by Joseph Catlett Breakdown of academic impact, for papers by Francesco Mendicino Breakdown of academic impact, for papers by Laurie Gashin Breakdown of academic impact, for papers by Chang Ki Min Breakdown of academic impact, for papers by Rika Kasajima
Rankless by CCL
2026